Register Login

Regeneron Pharmaceuticals Inc (REGN)

Director YANCOPOULOS GEORGE 🟡 adjusted position in 28.6K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.09 ($22.1M) Transaction Date: Dec 31, 2025 | Filing ID: 000002

Full text
Register to leave comments
  • News bot Jan. 6, 2026, 12:06 a.m.

    🔍 YANCOPOULOS GEORGE (Director)

    Company: REGENERON PHARMACEUTICALS, INC. (REGN)

    Report Date: 2025-12-31

    Transaction Summary:

    • Total transactions: 10
    • Derivative instruments: 1
    • Holdings reported: 7
    • Total shares acquired: 28,570
    • Total shares sold: 57,140
    • Total shares held: 815,485

    Detailed Transactions and Holdings:

    • Acquired 28,570 shares of Common Stock (Direct)
      Date: 2025-12-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 339,030.00 | transaction_form_type: 4
    • Sold 28,570 shares of Common Stock at $772.09 per share (Direct)
      Date: 2025-12-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 310,460.00 | transaction_form_type: 4
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-12-31 | Code: H | nature_of_ownership: By 2024 GRAT | shares_owned_after: 71,487.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-12-31 | Code: H | nature_of_ownership: By 2025 GRAT | shares_owned_after: 200,000.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-12-31 | Code: H | nature_of_ownership: By 2025 GRAT II | shares_owned_after: 200,000.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-12-31 | Code: H | nature_of_ownership: By 401(k) Plan | shares_owned_after: 5,962.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-12-31 | Code: H | nature_of_ownership: By Trust for Chldn. | shares_owned_after: 180,000.00 | Footnotes: F1
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-12-31 | Code: H | nature_of_ownership: by 2024 GRAT II | shares_owned_after: 101,988.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-12-31 | Code: H | nature_of_ownership: by Children | shares_owned_after: 56,048.00
    • Sold 28,570 shares of 2020 Performance Stock Units (Derivative)
      Date: 2025-12-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 595,077.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2

    Footnotes:

    • F1: As investment trustee of trusts for the benefit of the reporting person's children.
    • F2: Each performance restricted stock unit ("PSU") represents a contingent right to receive one share of Company stock. These PSUs were earned during the applicable five-year performance period and vested on December 31, 2025 but remain subject to a mandatory holding period of three years after vesting, which ends early upon the reporting person's death or disability or a change in control of the Company.

Search

News categories